Company strengthens financial position with improved margins, enhanced liquidity, and continued progress on transformation initiatives~ ...
Net revenues were $70.2 million, a decrease of 13.3% year-over-year. Gross profit was $7.2 million, or gross margin of 10.3%, compared to gross profit of $14.3 million, or gross margin of 17.7%, in ...
SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the third quarter 2025 and provided an update on the company’s recent developments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback